Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labor and premature rupture of membranes

References

• Svinarich DM, Wolf NA, Gomez R, et al. Detection of human defensin 5 in reproductive tissues. Am J Obstet Gynecol 1997;176:470–5
   PubMed Web of Science ®Google Scholar
• Eggert-Kruse W, Botz I, Pohl S, et al. Antimicrobial activity of human cervical mucus. Hum Reprod 2000;15: 778–84
   PubMed Web of Science ®Google Scholar
• Romero, R, Gomez, R, Araneda, H, et al. Cervical mucus inhibits microbial growth: a host defense mechnism to prevent ascending infection in pregnant and non-pregnant women. Am] Obstet Gynecol 1993;168:A57. (abstr)
   Google Scholar
• Hein M, Helmig RB, Schonheyder HC, et al. An in vitro study of antibacterial properties of the cervical mucus plug in pregnancy. Am] Obstet Gynecol 2001;185:586–92
   PubMed Web of Science ®Google Scholar
• Hein M, Valore EV, Helmig RB, et al. Antimicrobial factors in the cervical mucus plug. Am] Obstet Gynecol 2002;187:137–44
   PubMed Web of Science ®Google Scholar
• Kjaergaard N, Hein M, Hyttel L, et al. Antibacterial properties of human amnion and chorion in vitro. Eur J Obstet Gynecol Reprod Biol 2001;94:224–9
   PubMed Web of Science ®Google Scholar
• Talmi YP, Sigler L, Inge E, et al. Antibacterial properties of human amniotic membranes. Placenta 1991;12:285–8
   PubMed Web of Science ®Google Scholar
• Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nature Med 2000;6:589–93
   PubMed Web of Science ®Google Scholar
• Svinarich DM, Gomez R, Romero R. Detection of human defensins in the placenta. Am Reprod Immunol 1997; 38:252–5
   PubMed Web of Science ®Google Scholar
• Evaldson O, Malmborg AS, Nord CE, et al. Bacteroides fragilis, Streptococcus intermedius and group B streptococci in ascending infection of pregnancy. An animal experi-mental study. Gynecol Obstet Invest 1983;15:230–41
   PubMedGoogle Scholar
• Galask RP, Varner MW, Petzold CR, et al. Bacterial attachment to the chorioamniotic membranes. Am J Obstet Gynecol 1984;148:915–28
   PubMed Web of Science ®Google Scholar
• Cassell OH, Davis RO, Waites KB, et al. Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis 1983;10: 294–302
   PubMed Web of Science ®Google Scholar
• Gray DJ, Robinson HB, Malone J, et al. Adverse outcome in pregnancy following amniotic fluid isolation of Urea-plasma urealyticum Prenat Diagn 1992;12:111–17
   Google Scholar
• Horowitz S, Mazor M, Romero R, et al. Infection of the amniotic cavity with Ureaplasma urealyticum in the mid-trimester of pregnancy.] Reprod Med 1995;40:375–9
   PubMed Web of Science ®Google Scholar
• Bobitt JR, Ledger WJ. Amniotic fluid analysis. Its role in maternal neonatal infection. Obstet Gynecol 1978;51: 56–62
   Google Scholar
• Romero R, Sirtori M, Oyarzun E, et al Infection and labor. V. Prevalence, microbiology, and clinical significance of intraamniotic infection in women with preterm labor and intact membranes. Am] O bstet Gynecol 1989;161:817–24
   Google Scholar
• Romero R, Gomez R, Chaiworapongsa T, et al. The role of infection in preterm labour and delivery. Paediatr Perinat Epidemiol 2001;15 (Suppl 2):41–56
   PubMed Web of Science ®Google Scholar
• Romero R, Nores J, Mazor M, et al. Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance.] Reprod Med 1993;38:543–8
   PubMed Web of Science ®Google Scholar
• Miller J, Michel J, Bercovici B, et al Studies on the antimicrobial activity of amniotic fluid. Am J Obstet Gynecol 1976;125:212–14
   PubMed Web of Science ®Google Scholar
• Galask RP, Snyder IS. Antimicrobial factors in amniotic fluid. Am] Obstet Gynecol 1970;106:59–65
   PubMed Web of Science ®Google Scholar
• Thadepalli H, Appleman MD, Maidman JE, et al. Anti-microbial effect of amniotic fluid against anaerobic bacteria. Am] Obstet Gynecol 1977;127:250–54
   PubMedGoogle Scholar
• Tafari N, Ross SM, Naeye RL, et al. Failure of bacterial growth inhibition by amniotic fluid. Am] Obstet Gynecol 1977;128:187–9
   PubMed Web of Science ®Google Scholar
• Thadepalli H, Bach VT, Davidson EC, Jr. Antimicrobial effect of amniotic fluid. Obstet Gynecol 1978;52:198–204
   PubMed Web of Science ®Google Scholar
• Appelbaum PC, Shulman O, Chambers NL, et al. Studies on the growth-inhibiting property of amniotic fluids from two United States population groups. Am] Obstet Gynecol 1980;137:579–82
   PubMedGoogle Scholar
• Thadepalli H, Gangopadhyay PK, Maidman J E. Amniotic fluid analysis for antimicrobial factors. Int J Gynaecol Obstet 1982;20:65–72
   Google Scholar
• Ganz T, Selsted ME, Lehrer RI. Defensins. Eur J Haematol 1990;44:1–8
   PubMed Web of Science ®Google Scholar
• Spitznagel JK. Antibiotic proteins of human neutrophils. J Clin Invest 1990;86:1381–6
   PubMedGoogle Scholar
• Lehrer RI, Lichtenstein AK, Ganz T. Defensins: anti-microbial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993;11:105–28
   Google Scholar
• Ganz T. Biosynthesis of defensins and other antimicrobial peptides. Ciba Found Symp 1994;186:62–71
   PubMedGoogle Scholar
• Elsbach P, Weiss J. Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin. Curr Opin Immunol 1993;5:103–7
   PubMedGoogle Scholar
• Elsbach P, Weiss J. The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopolysaccharide. Immunobiology 1993;187:417–29
   PubMed Web of Science ®Google Scholar
• Calafat J, Janssen H, Tool A, et al. The bactericidal/ permeability-increasing protein (BPI) is present in specific granules of human eosinophils. Blood 1998;91: 4770–5
   PubMed Web of Science ®Google Scholar
• Calafat J, Janssen H, Knol EF, et al. The bactericidal/ permeability-increasing protein (BPI) is membrane-associated in azurophil granules of human neutrophils, and relocation occurs upon cellular activation. APMIS 2000;108:201–8
   PubMedGoogle Scholar
• Levy O. A neutrophil-derived anti-infective molecule: bactericidal/permeability-increasing protein. Antimicrob Agents Chemother 2000;44:2925–31
   PubMedGoogle Scholar
• Levy O. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 2000; 96:2664–72
   PubMedGoogle Scholar
• Dale I, Brandtzaeg P, Fagerhol MK, et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immuno-peroxidase staining features in comparison with lysozyme and lactoferrin. Am] Clin Pathol 1985;84:24–34
   Google Scholar
• Lehrer RI. Holocrine secretion of calprotectin: a neutrophil-mediated defense against Candida albicans? J Lab Clin Med 1993;121:193–4
   PubMedGoogle Scholar
• Voganatsi A, Panyutich A, Miyasaki KT, et al. Mechanism of extracellular release of human neutrophil calprotectin complex.] Leukoc Biol 2001;70:130–4
   PubMed Web of Science ®Google Scholar
• Pacora P, Chaiworapongsa T, Maymon E, et al. Funisitis and chorionic vasculitis: the histological counterpart of the fetal inflammatory response syndrome. J Matern Fetal Neonatal Med 2002;11:18–25
   PubMedGoogle Scholar
• Janeway CA Jr. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 1989;54:1–13
   PubMedGoogle Scholar
• Janeway C. Immunogenicity signals 1,2,3 . . . and 0. Immunol Today 1989;10:283–6
   PubMedGoogle Scholar
• Janeway CA, Travers P, Walport M, et al. Innate immunity. In Janeway CA, Travers P, Walport M, et al., eds. Immunobiology, 5th edn. New York: Garland Publishing, 2001:35–42
   Google Scholar
• Janeway CA Jr, Medzhitov R. Innate immune recogni-tion. Annu Rev Immunol 2002;20:i97-2i6
   Google Scholar
• Medzhitov R, Janeway CA Jr. Decoding the patterns of self and nonself by the innate immune system. Science 2002;296:298–300
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides in health and disease. N Engl J Med 2002;347:1199–200
   PubMed Web of Science ®Google Scholar
• Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002;4i5:389–95
   Google Scholar
• Zasloff M. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 1987;84:5449–53
   PubMed Web of Science ®Google Scholar
• Risso A, Zanetti M, Gennaro R. Cytotoxicity and apoptosis mediated by two peptides of innate immunity. Cell Immunol 1998;189:107–15
   Google Scholar
• Matsuzaki K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1999;1462:1–10
   PubMed Web of Science ®Google Scholar
• Shai Y. Mechanism of the binding, insertion and de-stabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1999; 1462:55–70
   PubMed Web of Science ®Google Scholar
• Yang L, Weiss TM, Lehrer RI, et al. Crystallization of antimicrobial pores in membranes: magainin and pro-tegrin. Biophys] 2000;79:2002–9
   PubMed Web of Science ®Google Scholar
• Breukink E, de Kruijff B. The lantibiotic nisin, a special case or not? Biochim Biophys Acta 1999;1462:223–34
   PubMed Web of Science ®Google Scholar
• Hirsch J. Phagocytin: a bactericidal sustance from poly-morphonuclear leukocytes.] Exp Med 1956;103:589–621
   PubMed Web of Science ®Google Scholar
• Weiss J, Kao L, Victor M, et al. Oxygen-independent intracellular and oxygen-dependent extracellular killing of Escherichia coli S15 by human polymorphonuclear leukocytes.] Clin Invest 1985;76:206–12
   PubMedGoogle Scholar
• Levy O. Antibiotic proteins of polymorphonuclear leukocytes. Eur J Haematol 1996;56:263–77
   PubMedGoogle Scholar
• Chertov O, Yang D, Howard OM, et al. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000;177:68–78
   PubMed Web of Science ®Google Scholar
• Yang D, Chen Q, Chertov O, et al. Human neutrophil defensins selectively chemoattract naive T and immature dendritic cells.] Leukoc Biol 2000;68:9–14
   PubMed Web of Science ®Google Scholar
• Yang D, Chertov O, Bykovskaia SN, et al Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999;286:525–8
   PubMed Web of Science ®Google Scholar
• Zuckerman H, Kahana A, Carmel S. Antibacterial activity of human cervical mucus. Gynecol Invest 1975; 6:265–71
   Google Scholar
• Valore EV, Park CH, Igreti SL, et al. Antimicrobial components of vaginal fluid. Am] Obstet Gynecol 2002; 187:561–8
   PubMed Web of Science ®Google Scholar
• Pacora P, Maymon E, Gervasi MT, et al Lactoferrin in intrauterine infection, human parturition, and rupture of fetal membranes. Am] Obstet Gynecol 2000;183:904–10
   PubMed Web of Science ®Google Scholar
• Baumann P, Romero R, Wilson T. [Role of gravidin, a phospholipase A2 inhibitor, in uterine contraction]. Gynakol G eburtshilfliche Ruildsch 1998;38: 16–20
   Google Scholar
• Helmig R, Romero R, Espinoza J, et al. Neutrophil elastase and secretory leukocyte protease inhibitor in prelabor rupture of membranes, parturition and intra-amniotic infection.] Perinat Med 2002;12:237–46
   Google Scholar
• Maymon E, Romero R, Pacora P, et al. Human neutrophil collagenase (matrix metalloproteinase 8) in parturition, premature rupture of the membranes, and intrauterine infection. Am] Obstet Gynecol 2000;183:94–9
   PubMed Web of Science ®Google Scholar
• Maymon E, Romero R, Chaiworapongsa T, et al. Value of amniotic fluid neutrophil collagenase concentrations in preterm premature rupture of membranes. Am] Obstet Gynecol 2001;185:1143–8
   PubMed Web of Science ®Google Scholar
• Maymon E, Romero R, Chaiworapongsa T, et al. Amniotic fluid matrix metalloproteinase-8 in preterm labor with intact membranes. Am J Obstet Gynecol 2001;185: 1149–55
   PubMed Web of Science ®Google Scholar
• Maymon E, Romero R, Pacora P, et al. Matrilysin (matrix metalloproteinase 7) in parturition, premature rupture of membranes, and intrauterine infection. Am J Obstet Gynecol 2000;182:1545–53
   PubMed Web of Science ®Google Scholar
• Yang D, Biragyn A, Kwak LW, et al. Mammalian defensins in immunity: more than just microbicidal. Trends Immunol 2002;23:291–6
   PubMed Web of Science ®Google Scholar
• Ouellette AJ, Selsted ME. Paneth cell defensins: endo-genous peptide components of intestinal host defense. FASEB J 1996;10:1280–9
   PubMed Web of Science ®Google Scholar
• Ganz T, Lehrer RI. Antimicrobial peptides of leukocytes. Curr Opin Hematol 1997;4:53–8
   PubMedGoogle Scholar
• Lehrer RI, Ganz T. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 1999;11:23–7
   PubMed Web of Science ®Google Scholar
• Zhao C, Wang I, Lehrer RI. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 1996;396: 319–22
   Google Scholar
• McCray PB Jr, Bentley L. Human airway epithelia express a beta-defensin. Am Respir Cell Mol Biol 1997;16:343–9
   PubMedGoogle Scholar
• Ali RS, Falconer A, Ikram M, et al. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 2001;117:106–11
   PubMed Web of Science ®Google Scholar
• Tang YQ, Yuan J, Osapay O, et al. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science 1999;286:498–502
   PubMed Web of Science ®Google Scholar
• Ganz T, Lehrer RI. Antimicrobial peptides of vertebrates. Curr Opin Immunol 1998;10:41–4
   PubMed Web of Science ®Google Scholar
• Bastian A, Schafer H. Human alpha-defensin 1 (HNP-1) inhibits adenoviral infection in vitro. Regul Pept 2001; 101:157–61
   PubMedGoogle Scholar
• Panyutich AV, Panyutich EA, Krapivin VA, et al. Plasma defensin concentrations are elevated in patients with septicemia or bacterial meningitis.] Lab Clin Med 1993; 122:202–7
   PubMed Web of Science ®Google Scholar
• Heine RP, Wiesenfeld H, Mortimer L, et al. Amniotic fluid defensins: potential markers of subclinical intra-uterine infection. Clin Infect Dis 1998;27:513–18
   PubMed Web of Science ®Google Scholar
• Ihi T, Nakazato M, Mukae H, et al. Elevated concentra-tions of human neutrophil peptides in plasma, blood, and body fluids from patients with infections. Clin Infect Dis 1997;25:1134–40
   PubMedGoogle Scholar
• Weersink AJ, van Kessel KP, van den Tol ME, etal. Human granulocytes express a 55 -kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein.] Immunol 1993;150:253–63
   PubMedGoogle Scholar
• Elsbach P, Weiss J. Role of the bactericidal/permeability-increasing protein in host defence. Curr Opin Immunol 1998;10:45–9
   PubMedGoogle Scholar
• Wiese A, Brandenburg K, Carroll SF, et al. Mechanisms of action of bactericidal/permeability-increasing protein BPI on reconstituted outer membranes of gram-negative bacteria. Biochemistry 1997;36:10311–19
   PubMedGoogle Scholar
• Wiese A, Brandenburg K, Lindner B, et al. Mechanisms of action of the bactericidal/permeability-increasing protein BPI on endotoxin and phospholipid monolayers and aggregates. Biochemistry 1997;36:10301–10
   PubMedGoogle Scholar
• Iovine NM, Elsbach P, Weiss J. An opsonic function of the neutrophil bactericidal/permeability-increasing pro- tein depends on both its N- and C-terminal domains. Proc N atl Acad Sci USA 1997;94:10973–8
   Google Scholar
• Nishimura H, Gogami A, Miyagawa Y, et al. Bacteri-cidal/permeability-increasing protein promotes comple-ment activation for neutrophil-mediated phagocytosis on bacterial surface. Immunology 2001;103:519–25
   PubMedGoogle Scholar
• Marra MN, Wilde CO, Griffith JE, et al. Bactericidal/ permeability-increasing protein has endotoxin-neutralizing activity.] Immunol 1990;144:662–6
   PubMed Web of Science ®Google Scholar
• Elsbach P, Weiss J, Doerfler M, et al. The bactericidal/ permeability increasing protein of neutrophils is a potent antibacterial and anti-endotoxin agent in vitro and in vivo. Prog Clin Biol Res 1994;388:41–51
   PubMedGoogle Scholar
• Levy O, Martin S, Eichenwald E, et al. Impaired innate immunity in the newborn: newborn neutrophils are deficient in bactericidal/permeability-increasing protein. Pediatrics 1999;104:1327–33
   PubMed Web of Science ®Google Scholar
• Wong HR, Doughty LA, Wedel N, et al. Plasma bactericidal/permeability-increasing protein concentra-tions in critically ill children with the sepsis syndrome. Pediatr Infect Dis] 1995;14:1087–91
   Google Scholar
• Calvano SE, Thompson WA, Marra MN, et al Changes in polymorphonuclear leukocyte surface and plasma bactericidal/permeability-increasing protein and plasma lipopolysaccharide binding protein during endotoxemia or sepsis. Arch Surg 1994;129:220–6
   PubMedGoogle Scholar
• der Mohlen MA, van der PT, Jansen J, et al Release of bactericidal/permeability-increasing protein in experi-mental endotoxemia and clinical sepsis. Role of tumor necrosis factor.] Immunol 1996;156:4969–73
   Google Scholar
• der Mohlen MA, Kimmings AN, Wedel NI, et al. Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. J Infect Dis 1995;172:144–51
   PubMedGoogle Scholar
• Rogy MA, Oldenburg HS, Calvano SE, et al The role of bactericidal/permeability-increasing protein in the treatment of primate bacteremia and septic shock. J Clin Immunol 1994;14:120–33
   PubMedGoogle Scholar
• McNamara MP, Wiessner JH, Collins-Lech C, et al. Neutrophil death as a defence mechanism against Candida albicans infections. Lancet 1988;2:1163–5
   Google Scholar
• Sohnle PG, Collins-Lech C, Wiessner JH. Antimicrobial activity of an abundant calcium-binding protein in the cytoplasm of human neutrophils. J Infect Dis 1991;163: 187–92
   PubMed Web of Science ®Google Scholar
• Steinbakk M, Naess-Andresen CF, Lingaas E, et al. Anti-microbial actions of calcium binding leucocyte Li protein, calprotectin. Lancet 1990;336:763–5
   PubMed Web of Science ®Google Scholar
• Dale I, Fagerhol MK, Naesgaard I. Purification and partial characterization of a highly immunogenic human leuko-cyte protein, the Li antigen. Eurf Biochem 1983;134:1–6
   Google Scholar
• Dorin JR, Novak M, Hill RE, et al. A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature (London) 1987;326:614–17
   PubMed Web of Science ®Google Scholar
• Odink K, Cerletti N, Bruggen J, et al. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature (London) 1987;330:80–2
   PubMed Web of Science ®Google Scholar
• van Heyningen, V, Dorin J. Possible role for two calcium-binding proteins of the S-100 family, co-expressed in granulocytes and certain epithelia. Adv Exp Med Biol 1990;269: 139–43
   Google Scholar
• Brandtzaeg P, Gabrielsen TO, Dale I, et al. The leucocyte protein Li (calprotectin): a putative nonspecific defence factor at epithelial surfaces. Adv Exp Med Biol 1995; 371A:201–6
   PubMedGoogle Scholar
• Clohessy PA, Golden BE. Calprotectin-mediated zinc chelation as a biostatic mechanism in host defence. Scam' J Immunol 1995;42:551–6
   PubMed Web of Science ®Google Scholar
• Pechkovsky DV, Zalutskaya OM, Ivanov GI, et al. Calprotectin (MRP8/14 protein complex) release during mycobacterial infection in vitro and in vivo. FEMS Immunol Med Microbiol 2000;29:27–33
   PubMed Web of Science ®Google Scholar
• Sampson JE, Theve RP, Blatman RN, et al. Fetal origin of amniotic fluid polymorphonuclear leukocytes. Am J Obstet Gynecol 1997;176:77–81
   PubMed Web of Science ®Google Scholar
• Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000;1:141–50
   PubMedGoogle Scholar
• Schmidt B, Cao L, Mackensen-Haen S, et al. Chorio-amnionitis and inflammation of the fetal lung. Am] Obstet Gynecol 2001;185:173–7
   PubMed Web of Science ®Google Scholar
• Romero R, Manogue KR, Mitchell MD, et al. Infection and labor. IV. Cachectin—tumor necrosis factor in the amniotic fluid of women with intraamniotic infection and preterm labor. Am] Obstet Gynecol 1989;161:336–41
   Google Scholar
• Romero R, Parvizi ST, Oyarzun E, et al. Amniotic fluid interleukin-1 in spontaneous labor at term. J Reprod Med 1990;35:235–8
   PubMed Web of Science ®Google Scholar
• Romero R, Gomez R, Ghezzi F, et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am] Obstet Gynecol 1998; 179:186–93
   PubMed Web of Science ®Google Scholar
• Athayde N, Romero R, Gomez R, et al. Matrix metalloproteinases-9 in preterm and term human parturition. J Matem Fetal Med 1999;8:213–19
   PubMedGoogle Scholar
• Maymon E, Ghezzi F, Edwin SS, et al. The tumor necrosis factor alpha and its soluble receptor profile in term and preterm parturition. Am J Obstet Gynecol 1999;181: 1142–48
   PubMed Web of Science ®Google Scholar
• Athayde N, Romero R, Maymon E, et al. Interleukin 16 in pregnancy, parturition, rupture of fetal membranes, and microbial invasion of the amniotic cavity. Am] Obstet Gynecol 2000;182:135–41
   PubMed Web of Science ®Google Scholar
• Maymon E, Romero R, Pacora P, et al Evidence for the participation of interstitial collagenase (matrix metallo-proteinase 1) in preterm premature rupture of membranes. Am] Obstet Gynecol 2000;183:914— 20
   PubMedGoogle Scholar
• Maymon E, Romero R, Pacora P, et al. Evidence of in vivo differential bioavailability of the active forms of matrix metalloproteinases 9 and 2 in parturition, spontaneous rupture of membranes, and intra-amniotic infection. Am] Obstet Gynecol 2000;183:887–94
   PubMed Web of Science ®Google Scholar
• Maymon E, Romero R, Pacora P, et al. A role for the 72 kDa gelatinase (MMP-2) and its inhibitor (TIMP-2) in human parturition, premature rupture of membranes and intraamniotic infection.] Perinat Med 2001;29:308–16
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Moon JB, et al Clinical significance of intra-amniotic inflammation in patients with preterm labor and intact membranes. Am] Obstet Gynecol 2001; 185:1130–6
   PubMed Web of Science ®Google Scholar
• Romero R, Yoon BH, Kenney JS, et al. Amniotic fluid interleukin-6 determinations are of diagnostic and prognostic value in preterm labor. Am] Reprod Immunol i993;30:167–83
   Google Scholar
• Yoon BH, Romero R, Kim M, et al. Clinical implications of detection of Ureaplasma urealyticum in the amniotic cavity with the polymerase chain reaction. Am] Obstet Gynecol 2000;183:1130— 7
   PubMedGoogle Scholar
• Hitti J, Riley DE, Krohn MA, et al. Broad-spectrum bacterial rDNA polymerase chain reaction assay for detecting amniotic fluid infection among women in pre-mature labor. Clin Infect Dis 1997;24:1228–32
   PubMed Web of Science ®Google Scholar
• Markenson GR, Martin RK, Tillotson-Criss M, et al The use of the polymerase chain reaction to detect bacteria in amniotic fluid in pregnancies complicated by preterm labor. Am] Obstet Gynecol 1997;177:1471–7
   PubMed Web of Science ®Google Scholar
• Santhanam U, Avila C, Romero R, et al Cytokines in normal and abnormal parturition: elevated amniotic fluid interleukin-6 levels in women with premature rupture of membranes associated with intrauterine infec-tion. Cytokine 1991;3:155–63
   PubMed Web of Science ®Google Scholar
• Dudley DJ, Collmer D, Mitchell MD, et al. Inflammatory cytokine mRNA in human gestational tissues: implica-tions for term and preterm labor. J Soc Gynecol Invest 1996;3:328–35
   PubMedGoogle Scholar
• Ammala M, Nyman T, Salmi A, et al. The interleukin-1 system in gestational tissues at term: effect of labour. Placenta 1997;18:717–23
   PubMed Web of Science ®Google Scholar
• Keelan JA, Marvin KW, Sato TA, et al Cytokine abundance in placental tissues: evidence of inflammatory activation in gestational membranes with term and pre-term parturition. Am] Obstet Gynecol 1999;181:1530–6
   PubMed Web of Science ®Google Scholar